Semler Scientific cuts its IPO price range to $7.50-$9.50 per share.
Semler Scientific is lowering its IPO price, now seeking $10 million instead of the previous $15 million it desired.
Portland, Ore.-based Semler specializes in medical risk-assessment. The company's flagship product is the FloChec, which tracks blood flow in lower and upper extremities. The device is cleared by the FDA, according to the company's website.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1emKotO
Cap comentari:
Publica un comentari a l'entrada